Outcome | No. studies | Length of INT (Weeks) | Sample size (N): INT + CONT at follow-up | Mean agea | Femaleb (%) | Summary effect | Heterogeneity | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hedges’ g | SE | 95% CI | p value | Q | Df (Q) | p value | I2 (%) | ||||||
Depressive symptoms | 6 | 9–52 | 1703 | 12.09 | 49 | − 0.006 | 0.101 | − 0.204; 0.193 | 0.954 | 12.394 | 5 | 0.030 | 59 |
Anxiety | 6 | 6–15 | 1060 | 14.79 | 51 | 0.347 | 0.140 | 0.072; 0.623 | 0.013 | 13.739 | 5 | 0.017 | 64 |
Emotional problems | 5 | 8–52 | 2654 | 9.43 | 60 | − 0.038 | 0.091 | − 0.217; 0.141 | 0.678 | 17.468 | 4 | 0.002 | 77 |
Well-being | 10 | 4–52 | 4565 | 11.18 | 52 | 0.877 | 0.266 | 0.356; 1.398 | 0.001 | 553.337 | 9 | < 0.001 | 98 |
Health-related quality of life | 11 | 4–52 | 7387 | 10.44 | 66 | 0.085 | 0.048 | − 0.010; 0.179 | 0.078 | 33.983 | 10 | < 0.001 | 71 |
Self-esteem, self-worth | 10 | 8–52 | 5869 | 12.79 | 67 | 0.107 | 0.102 | − 0.092; 0.307 | 0.292 | 76.414 | 9 | < 0.001 | 88 |
Resilience | 4 | 8–11 | 437 | 14.16 | 49 | 0.748 | 0.215 | 0.326; 1.170 | 0.001 | 10.478 | 3 | 0.015 | 71 |
Positive effect | 5 | 4–18 | 676 | 11.10 | 50 | 0.055 | 0.079 | − 0.100; 0.211 | 0.486 | 4.083 | 4 | 0.395 | 2 |
Negative effect | 5 | 4–18 | 676 | 11.10 | 50 | − 0.318 | 0.500 | − 1.298; 0.662 | 0.525 | 53.24 | 3 | < 0.001 | 94 |
Internalising problems | 16 | 4–52 | 5045 | 10.21 | 55 | 0.015 | 0.062 | − 0.107; 0.137 | 0.814 | 52.289 | 15 | < 0.001 | 71 |
Positive mental health | 26 | 4–52 | 12565 | 10.77 | 61 | 0.405 | 0.101 | 0.208; 0.603 | < 0.001 | 637.615 | 25 | < 0.001 | 96 |